ReviewCancers2023

MET Amplification as a Resistance Driver to TKI Therapies in Lung Cancer: Clinical Challenges and Opportunities.

Kang Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.